Skip to main content
. Author manuscript; available in PMC: 2020 Feb 17.
Published in final edited form as: Nano Lett. 2019 Feb 18;19(3):1883–1891. doi: 10.1021/acs.nanolett.8b04970

Figure 2.

Figure 2.

Binding efficiency of P-CD34 to EPCs. (A) A schematic showing the experimental design for P-CD34 targeting to EPCs. (B) Fluorescent micrographs confirming the ability of P-CD34 to capture EPC. DiI-labeled EPC were incubated with platelet, P-IgG, and P-CD34. CD34 blockage was used as a control. (C) Schematic showing the experimental design for capturing EPCs in whole blood using different samples. (D) Flow cytometry analysis showing the ability of P-CD34 to capture EPCs in whole blood. The 105 DiI-labeled EPCs were mixed with the whole blood before the addition of different capturing agents. Scale bar: 10 μm